SCHEMBL2434556

SCHEMBL2434556

CC=CCOC(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
TDP1 Q9NUW8 2/20 0.53
MAPK1 P28482 1/20 0.52
HIF1A Q16665 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A3 Q01959 1/20 0.52
KMT2A Q03164 1/20 0.52
TSHR P16473 2/20 0.51
ALDH1A1 P00352 2/20 0.50
TK1 P04183 1/20 0.50
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
F2 P00734 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
AKT1 P31749 1/20 0.46
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15450091 1.00 LMNA (0.55) LMNATDP1MAPK1HIF1ASLC6A2
SCHEMBL15869135 1.00 LMNA (0.55) LMNATDP1MAPK1HIF1ASLC6A2
SCHEMBL22492979 0.90 TRPV1 (0.47) LMNATDP1MAPK1SLC6A2KMT2A
SCHEMBL1680326 0.90 TRPV1 (0.47) LMNATDP1MAPK1SLC6A2KMT2A
SCHEMBL8522570 0.88 TDP1 (0.61) LMNATDP1MAPK1HIF1ASLC6A2
SCHEMBL8522569 0.88 TDP1 (0.61) LMNATDP1MAPK1HIF1ASLC6A2
SCHEMBL8078151 0.88 TDP1 (0.61) LMNATDP1MAPK1HIF1ASLC6A2
SCHEMBL18204470 0.88 LMNA (0.50) LMNATDP1MAPK1HIF1ASLC6A2
SCHEMBL15978100 0.88 LMNA (0.50) LMNATDP1MAPK1HIF1ASLC6A2
Ethyl Benzoate SCHEMBL30786690 0.88 SMN1; SMN2 (0.52) LMNAMAPK1KMT2ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9279085-B2 Method for the production of monofunctionalized dialkylphosphinic acids, esters and salts, and use thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2016-03-08 US claimed
US-8735476-B2 Method for producing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts using a vinyl ester of a carboxylic acid and the use thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2014-05-27 US claimed
EP-2373667-B1 METHOD FOR PRODUCING MONO-CARBOXY-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS USING A VINYL ESTER OF A CARBOXYLIC ACID AND THE USE THEREOF CLARIANT FINANCE BVI LTD (VG) 2013-12-11 EP claimed
US-20110237721-A1 Method for Producing Mono-Carboxy-Functionalized Dialkylphosphinic Acids, Esters and Salts Using a Vinyl Ester of a Carboxylic Acid and the Use Thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2011-09-29 US claimed
US-9279085-B2 Method for the production of monofunctionalized dialkylphosphinic acids, esters and salts, and use thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2016-03-08 US disclosed
US-8735476-B2 Method for producing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts using a vinyl ester of a carboxylic acid and the use thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2014-05-27 US disclosed
US-20110251315-A1 Method for the Production of Monofunctionalized Dialkylphosphinic Acids, Esters and Salts, and Use Thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2011-10-13 US disclosed
US-20110237721-A1 Method for Producing Mono-Carboxy-Functionalized Dialkylphosphinic Acids, Esters and Salts Using a Vinyl Ester of a Carboxylic Acid and the Use Thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2011-09-29 US disclosed
EP-0293908-B1 Molding material for optics MITSUBISHI GAS CHEMICAL CO (JP) 1994-04-06 EP disclosed
US-4888401-A GRAFT POLYMERS OF STYRENE WITH MALEIC ANHYDRIDE OR MALEIMIDE AND AROMATIC POLYCARBONATES MITSUBISHI GAS CHEMICAL CO., LTD. (JP) 1989-12-19 US disclosed
EP-0293908-A2 Molding material for optics MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1988-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237721-A1 Method for Producing Mono-Carboxy-Functionalized Dialkylphosphinic Acids, Esters and Salts Using a Vinyl Ester of a Carboxylic Acid and the Use Thereof SCO2, HAO2, DAO LMNA 2720/4885TDP1 4460/4885MAPK1 3164/4885
US-20110251315-A1 Method for the Production of Monofunctionalized Dialkylphosphinic Acids, Esters and Salts, and Use Thereof LPAR6, LPAR2, HAO2 LMNA 3960/4885TDP1 4776/4885MAPK1 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.